Chiu Chia-Yu, Sarwal Amara, Azhar Munir Rehan, Widjaja Michael, Khalid Amna, Khanna Rajan
Department of Medicine, Lincoln Medical Center, Bronx, NY, USA.
Am J Case Rep. 2020 Sep 18;21:e926561. doi: 10.12659/AJCR.926561.
BACKGROUND Use of selective serotonin reuptake inhibitors (SSRIs) has been reported to be associated with the syndrome of inappropriate antidiuretic hormone (SIADH), although it is uncommon. Nonsteroidal anti-inflammatory drugs (NSAIDs), as a sole agent, are an even rarer cause of SIADH. Despite being documented in the literature, the understanding of the mechanism of both agents is limited. Here, we report a case of a patient taking both of these medications, a dangerous combination that led to the development of SIADH. CASE REPORT An 88-year-old woman with a history of asymptomatic chronic hyponatremia presented to our facility with symptomatic acute-on-chronic hyponatremia after she started using naproxen in addition to her daily citalopram. Her hyponatremia symptoms resolved after discontinuing these 2 offending agents, along with administration of fluid restriction and oral sodium supplements. CONCLUSIONS Naproxen is commonly prescribed and is often taken by elderly patients to control long-term or short-term pain. SSRIs, on the other hand, are a first-line treatment for depression and are usually prescribe by a psychiatrist. Hyponatremia is a rare medication adverse effect that should be kept in mind when treating these patients with either of these medications, and should especially be considered when combining them. Medication reconciliation should be done carefully by the provider to avoid adverse effects and drug interactions. When hyponatremia is encountered, options for future medication prescriptions include rechallenging with the same medication, switching to a different medication with the same mechanism of action, or using a medication from another class altogether. Monitoring of serum sodium level is warranted when titrating the offending agent.
据报道,使用选择性5-羟色胺再摄取抑制剂(SSRI)与抗利尿激素分泌异常综合征(SIADH)有关,尽管这种情况并不常见。非甾体抗炎药(NSAID)作为单一药物,是导致SIADH的更罕见原因。尽管文献中有记载,但对这两种药物作用机制的了解有限。在此,我们报告一例同时服用这两种药物的患者,这种危险的组合导致了SIADH的发生。病例报告:一名88岁有无症状慢性低钠血症病史的女性,在开始每日服用西酞普兰的基础上又加用萘普生后,因症状性慢性低钠血症急性加重而前来我院就诊。停用这两种致病药物,并给予限液和口服补钠治疗后,她的低钠血症症状得到缓解。结论:萘普生是常用处方药,老年患者常服用以控制长期或短期疼痛。另一方面,SSRI是抑郁症的一线治疗药物,通常由精神科医生开具。低钠血症是一种罕见的药物不良反应,在使用这两种药物治疗患者时均应牢记,尤其是两种药物联用时更应考虑。医疗服务提供者应仔细进行用药核对,以避免不良反应和药物相互作用。当出现低钠血症时,未来药物处方的选择包括重新使用同一种药物、换用作用机制相同的另一种药物或完全换用另一类药物。在调整致病药物剂量时,有必要监测血清钠水平。